The healthcare industry has notoriously struggled with disconnected data systems and a lack of interoperability. When health information cannot be easily exchanged between different systems and ...

Redox, the leading healthcare data interoperability partner, today announced the launch of several artificial intelligence (AI) capabilities integrated across Redox Engine, the company's ...

It’s time to move health data to the front of the line. It gets a lot of lip service, indeed, but there hasn’t been enough focus on how information is captured, stored, and used to treat patients, nor ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Health care leaders have long envisioned a world in which patient ...

An AI model developed by Northwestern Medicine investigators improved the transformation of EHR data into standardized health resources more efficiently than current methods, according to a recent ...

Attendees at HIMSS24 next week can home in on health information exchange issues with the day-long Interoperability & HIE Forum taking place Monday, March 11, in Orlando, Florida. Hosted by HIMSS ...

Interoperability has been a longstanding goal for healthcare: The promise of being able to exchange data seamlessly between health information networks has been a goal the industry has been working ...

The increasing healthcare digitization has developed a situation in which massive amounts of clinical and operations information are being created on a daily basis in hospitals, laboratories, and ...

With the increasing demand for enhanced patient care, the healthcare sector stands at the crossroads of innovation and challenge. Notably, interoperability is recognized as one of the main principles ...

Arpan Saxena is the Head of Product at basys.ai (based out of Harvard University), a leading healthcare AI solutions company. In healthcare, we often face a dilemma: How do we get data to move ...

Informatics and Artificial Intelligence–Guided Assessment of the Regulatory and Translational Research Landscape of First-in-Class Oncology Drugs in the United States, 2018-2022 Our approach used an ...